Visualizing the future: enhancing neuroimaging with nanotechnology (Q33943013)

30 July 2017

1 reference

title

Visualizing the future: enhancing neuroimaging with nanotechnology (English)

1 reference

30 July 2017

0 references

0 references

1 reference

Jesse L Winer

1 reference

30 July 2017

Paul E Kim

1 reference

30 July 2017

Meng Law

1 reference

30 July 2017

Charles Y Liu

1 reference

30 July 2017

Michael L J Apuzzo

1 reference

30 July 2017

publication date

1 May 2011

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

issue

5-6

1 reference

30 July 2017

page(s)

626-37; discussion 618-9

1 reference

An overview of the clinical pharmacokinetics of x-ray contrast media

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Relaxometry and magnetometry of the MR contrast agent MION-46L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Next-generation optical technologies for illuminating genetically targeted brain circuits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Optogenetic Approaches in Neuroscience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Optical deconstruction of parkinsonian neural circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Gold microspheres: a selective technique for producing biologically effective dose enhancement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Global and local fMRI signals driven by neurons defined optogenetically by type and wiring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Evolution of diagnostic neuroradiology from 1904 to 1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Remote control of behavior through genetically targeted photostimulation of neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Electrostatic nanolithography in polymers using atomic force microscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Innovations in the imaging of brain functions using fluorescent proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Uses of nanoparticles for central nervous system imaging and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Update on neuroimaging in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Nanostructures in biodiagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Bioresponsive nanosensors in medical imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Protease-specific nanosensors for magnetic resonance imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

From Atom to Brain: Applications of Molecular Imaging to Neurosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Molecular Imaging, Part 1: Apertures into the Landscape of Genomic Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Targeting alzheimer amyloid plaques in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2011.02.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.WNEU.2011.02.016

1 reference

30 July 2017

1 reference